Clinical Trial: Assessment of Screening Modalities for Gynecologic Cancers

Share this article:
Clinical Trial: Assessment of Screening Modalities for Gynecologic Cancers

Sponsor and Collaborators

National Cancer Institute (NCI)

Contact
Contact: Mark E. Sherman, M.D.
(301) 594-7661
Mark.Sherman@nih.hhs.gov

ClinicalTrials.gov Identifier
NCT00879840
Share this article:
You must be a registered member of ONA to post a comment.
close

Next Article in Gynecologic Cancer Clinical Trials

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Gynecologic Cancer Clinical Trials

Clinical Trial: Validation of Sexual Function Scale in Gynecologic Cancer

Clinical trial focusing on sexual function in gynecologic cancer. Validation of Sexual Function Scale in Gynecologic Cancer

Clinical Trial: Media Diversion in Improving Quality of Life in Patients With ...

Clinical trial focusing on media diversion and gynecologic cancer. Media Diversion in Improving Quality of Life in Patients With Recurrent Gynecologic Cancers Receiving Chemotherapy

Clinical Trial: Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy ...

Clinical trial focusing on FloSeal and gynecologic cancer. Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer